Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 16, L.P.(12.0%),NEA Partners 16, L.P.(12.0%), etc.
Marker Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lurier Eliot M
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Eansor Norman David
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Knobil Katharine
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wilson John Robert
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELMS STEVE
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vera Juan
Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%), etc.
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data
No Data